Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Use of Pro-Angiogenic and/or Pro-Hypoxic miRNAs as Tools to Monitor Patients with Diffuse Gliomas.

International journal of molecular sciences - 27 May 2022

Levallet Guénaëlle, Dubois Fatéméh, Leclerc Arthur, Petit Edwige, Bekaert Lien, Faisant Maxime, Creveuil Christian, Emery Evelyne, Zalcman Gérard, Lechapt-Zalcman Emmanuèle

Abstract excerpt

IDH (isocitrate dehydrogenase) mutation, hypoxia, and neo-angiogenesis, three hallmarks of diffuse gliomas, modulate the expression of small non-coding RNAs (miRNA). In this paper, we tested whether pro-angiogenic and/or pro-hypoxic miRNAs could be used to monitor patients with glioma. The miRNAs were extracted from tumoral surgical specimens embedded in the paraffin of 97 patients with diffuse gliomas and, for 7...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Glioma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypoxia

Share to Isocitrate Dehydrogenase

Share to MicroRNAs

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 35682718
DOI: 10.3390/ijms23116042
PMCID: PMC9181142

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Use of Pro-Angiogenic and/or Pro-Hypoxic miRNAs as Tools to Monitor Patients with Diffuse Gliomas.PMID 35682718Read ↗

miRNAs and related genetic biomarkers according to the WHO glioma classification: From diagnosis to future therapeutic targetsSemantic proximity Read ↗

Long non-coding RNA in glioma: novel genetic players in temozolomide resistanceSemantic proximity Read ↗

[Advances of glioma biomarkers].Semantic proximity Read ↗

Genomic Profiling in Glioma Patients to Explore Clinically Relevant Markers.Semantic proximity Read ↗

The Role of miRNAs in the Progression and Prognosis of GliomasSemantic proximity Read ↗

Hypoxia drives shared and distinct transcriptomic changes in two invasive glioma stem cell linesSemantic proximity Read ↗

Machine learning-based integration develops a hypoxia-derived signature for improving outcomes in gliomaSemantic proximity Read ↗

Exploring the Potential Use of Non-coding RNAs as Possible Biomarkers for Glioma. Literature ReviewSemantic proximity Read ↗

A diagnostic circulating miRNA signature as orchestrator of cell invasion via TKS4/TKS5/EFHD2 modulation in human gliomasSemantic proximity Read ↗

Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?Semantic proximity Read ↗

Systematic Review of Molecular Targeted Therapies for Adult-Type Diffuse Glioma: An Analysis of Clinical and Laboratory Studies.Semantic proximity Read ↗

Identification of a Prognostic Hypoxia-Associated Gene Set in IDH-Mutant GliomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.